Has there been any recent news about Zyprexa?
In April 2005, the FDA issued an alert stating that older patients treated with atypical antipsychotic medicines, such as Zyprexa, for dementia had a higher chance for death than patients who did not take the medicine. The FDA stated further that this is not an approved use and has asked the companies that make these medicines to change their labels to include this important information.
